Remove 2023 Remove History Remove Medical Evaluation
article thumbnail

Microdosing Cannabis in Miami: What It Is and How It Might Help

LifeCannMD

A 2023 study in Cannabis and Cannabinoid Research validated this approach, showing that patients following slower titration schedules had 84% treatment satisfaction compared to 61% with faster increases. The Stanford Sleep Laboratory Findings Stanford’s Sleep Research Center studied 847 insomnia patients using different cannabis doses.

article thumbnail

DEA Pushes Marijuana Rescheduling Hearing To December: What Does This Mean For Cannabis?

Veriheal

In August 2023, the HHS also crucially recommended to the DEA that cannabis be relisted from Schedule I to Schedule III. This recommendation resulted from a thorough scientific and medical evaluation of cannabis by HHS, which determined that cannabis does have “currently accepted medical use” in the U.S.

DEA 97